Viewing Study NCT07411820


Ignite Creation Date: 2026-03-26 @ 3:20 PM
Ignite Modification Date: 2026-04-01 @ 2:39 AM
Study NCT ID: NCT07411820
Status: COMPLETED
Last Update Posted: 2026-02-17
First Post: 2026-02-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect of Kinesio Taping Combined With Postural Correction on Improving Tension-Type Headache Among University Students
Sponsor: Deraya University
Organization:

Study Overview

Official Title: Effect of Kinesio Taping Combined With Postural Correction on Improving Tension-Type Headache Among University Students
Status: COMPLETED
Status Verified Date: 2026-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study aims to evaluate the effectiveness of combining Kinesio Taping (KT) with postural correction exercises and suboccipital muscle inhibition (SMI) in managing tension-type headaches (TTH) among university students. The intervention's impact on headache intensity, frequency, and functional limitations will be compared with a control group performing postural correction and SMI alone.
Detailed Description: Tension-type headache (TTH) is a common primary headache associated with muscular tension, poor posture, and psychological stress. Physiotherapy interventions including deep neck flexor exercises, suboccipital muscle inhibition (SMI), and postural education have been shown to reduce pain and improve posture.

Kinesio Taping (KT) has been proposed as an adjunct that enhances proprioception, reduces muscle tension, and supports cervical alignment.

This randomized controlled trial will recruit 52 university students aged 18-25 years diagnosed with frequent episodic TTH according to ICHD-3 criteria. Participants will be randomly assigned to two groups:

Group A (Control): Postural correction + SMI Group B (Experimental): Kinesio Taping + Postural correction + SMI

Both groups will receive two treatment sessions per week for 4 weeks.

Assessments will be performed at baseline, after 4 weeks of treatment, and at a 1-month follow-up using validated measures for pain, frequency, and posture.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: